Risk factors analysis of prognosis of adult acute severe myocarditis.

BACKGROUND

Adult severe myocarditis is primarily caused by infection with any number of a variety of viruses. It arises quickly, progresses rapidly, and may lead to severe heart failure or circulatory failure presenting as rapid-onset hypotension and cardiogenic shock with a high hospital mortality rate.

AIM

To analyze the risk factors affecting the short-term prognosis of adult acute severe myocarditis (ASM).

METHODS

Adult patients with ASM (ASM group, = 218) and acute nonsevere myocarditis (ANSM group, = 80) who came to our department from January 2014 to January 2020 were enrolled in this study. Patients with ASM were divided into the ASM survival group ( = 185) and ASM nonsurvival group ( = 33) according to the treatment results during hospitalization. The clinical symptoms, laboratory examinations, treatment methods, complications, and the relationship between the treatment results of the two groups were retrospectively compared and discussed. The risk factors for death in patients with severe myocarditis were analyzed by binary logistic regression. A follow-up to 5.5 years was conducted on patients in the ASM survival group and ANSM group after discharge, and the readmission rate and incidence rate of dilated cardiomyopathy were analyzed.

RESULTS

Compared with the ASM survival group, the ASM nonsurvival group had longer QRS complex, higher incidence of cardiogenic shock, higher serum creatinine (SCr, 235μmol/L 89 μmol/L, < 0.05), higher sensitive cardiac troponin I (cTnI, 4.45 μg/L 1.66 μg/L, < 0.05) and brain natriuretic peptide (BNP, 1756 pg/mL 401 pg/mL, < 0.05). The binary logistic regression revealed that there were statistical differences between the two groups in SCr, cTnI, and BNP values (all < 0.05). After discharging from the hospital, patients in the ASM group and ANSM group had no significant differences in the readmission rate and incidence rate of dilated cardiomyopathy.

CONCLUSION

Elevated SCr, cTnI, and BNP are independent predictors for poor prognosis in patients with ASM. The long-term prognosis of patients in the ASM survival group is good.